Global Herpes Simplex Virus Infections Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Herpes Simplex Virus Infections Industry Forecast” looks at past sales and reviews total world Herpes Simplex Virus Infections sales in 2022, providing a comprehensive analysis by region and market sector of projected Herpes Simplex Virus Infections sales for 2023 through 2029. With Herpes Simplex Virus Infections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herpes Simplex Virus Infections industry.
This Insight Report provides a comprehensive analysis of the global Herpes Simplex Virus Infections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Herpes Simplex Virus Infections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herpes Simplex Virus Infections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herpes Simplex Virus Infections and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herpes Simplex Virus Infections.
The global Herpes Simplex Virus Infections market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Herpes Simplex Virus Infections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Herpes Simplex Virus Infections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Herpes Simplex Virus Infections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Herpes Simplex Virus Infections players cover Admedus Limited, Agenus Inc., Aicuris Anti-infective Cures Gmbh, Asahi Kasei Corporation, Chimerix Inc., Clinigen Group Plc, Daewoong Pharmaceutical Co., Ltd., F. Hoffmann-la Roche Ltd. and Glaxosmithkline Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus Infections market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Herpes Simplex Virus Infections Industry Forecast” looks at past sales and reviews total world Herpes Simplex Virus Infections sales in 2022, providing a comprehensive analysis by region and market sector of projected Herpes Simplex Virus Infections sales for 2023 through 2029. With Herpes Simplex Virus Infections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herpes Simplex Virus Infections industry.
This Insight Report provides a comprehensive analysis of the global Herpes Simplex Virus Infections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Herpes Simplex Virus Infections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herpes Simplex Virus Infections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herpes Simplex Virus Infections and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herpes Simplex Virus Infections.
The global Herpes Simplex Virus Infections market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Herpes Simplex Virus Infections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Herpes Simplex Virus Infections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Herpes Simplex Virus Infections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Herpes Simplex Virus Infections players cover Admedus Limited, Agenus Inc., Aicuris Anti-infective Cures Gmbh, Asahi Kasei Corporation, Chimerix Inc., Clinigen Group Plc, Daewoong Pharmaceutical Co., Ltd., F. Hoffmann-la Roche Ltd. and Glaxosmithkline Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus Infections market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- General Treatment
- Antiviral Therapy
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Admedus Limited
- Agenus Inc.
- Aicuris Anti-infective Cures Gmbh
- Asahi Kasei Corporation
- Chimerix Inc.
- Clinigen Group Plc
- Daewoong Pharmaceutical Co., Ltd.
- F. Hoffmann-la Roche Ltd.
- Glaxosmithkline Plc
- Maruho Co. Ltd.
- Merck
- Mylan
- Novartis
- Sanofi Pasteur
- Teva Pharmaceutical Industries Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Herpes Simplex Virus Infections Market Size 2018-2029
2.1.2 Herpes Simplex Virus Infections Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Herpes Simplex Virus Infections Segment by Type
2.2.1 General Treatment
2.2.2 Antiviral Therapy
2.3 Herpes Simplex Virus Infections Market Size by Type
2.3.1 Herpes Simplex Virus Infections Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
2.4 Herpes Simplex Virus Infections Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Herpes Simplex Virus Infections Market Size by Application
2.5.1 Herpes Simplex Virus Infections Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
3 HERPES SIMPLEX VIRUS INFECTIONS MARKET SIZE BY PLAYER
3.1 Herpes Simplex Virus Infections Market Size Market Share by Players
3.1.1 Global Herpes Simplex Virus Infections Revenue by Players (2018-2023)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2018-2023)
3.2 Global Herpes Simplex Virus Infections Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HERPES SIMPLEX VIRUS INFECTIONS BY REGIONS
4.1 Herpes Simplex Virus Infections Market Size by Regions (2018-2023)
4.2 Americas Herpes Simplex Virus Infections Market Size Growth (2018-2023)
4.3 APAC Herpes Simplex Virus Infections Market Size Growth (2018-2023)
4.4 Europe Herpes Simplex Virus Infections Market Size Growth (2018-2023)
4.5 Middle East & Africa Herpes Simplex Virus Infections Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Herpes Simplex Virus Infections Market Size by Country (2018-2023)
5.2 Americas Herpes Simplex Virus Infections Market Size by Type (2018-2023)
5.3 Americas Herpes Simplex Virus Infections Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herpes Simplex Virus Infections Market Size by Region (2018-2023)
6.2 APAC Herpes Simplex Virus Infections Market Size by Type (2018-2023)
6.3 APAC Herpes Simplex Virus Infections Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Herpes Simplex Virus Infections by Country (2018-2023)
7.2 Europe Herpes Simplex Virus Infections Market Size by Type (2018-2023)
7.3 Europe Herpes Simplex Virus Infections Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Herpes Simplex Virus Infections by Region (2018-2023)
8.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2018-2023)
8.3 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HERPES SIMPLEX VIRUS INFECTIONS MARKET FORECAST
10.1 Global Herpes Simplex Virus Infections Forecast by Regions (2024-2029)
10.1.1 Global Herpes Simplex Virus Infections Forecast by Regions (2024-2029)
10.1.2 Americas Herpes Simplex Virus Infections Forecast
10.1.3 APAC Herpes Simplex Virus Infections Forecast
10.1.4 Europe Herpes Simplex Virus Infections Forecast
10.1.5 Middle East & Africa Herpes Simplex Virus Infections Forecast
10.2 Americas Herpes Simplex Virus Infections Forecast by Country (2024-2029)
10.2.1 United States Herpes Simplex Virus Infections Market Forecast
10.2.2 Canada Herpes Simplex Virus Infections Market Forecast
10.2.3 Mexico Herpes Simplex Virus Infections Market Forecast
10.2.4 Brazil Herpes Simplex Virus Infections Market Forecast
10.3 APAC Herpes Simplex Virus Infections Forecast by Region (2024-2029)
10.3.1 China Herpes Simplex Virus Infections Market Forecast
10.3.2 Japan Herpes Simplex Virus Infections Market Forecast
10.3.3 Korea Herpes Simplex Virus Infections Market Forecast
10.3.4 Southeast Asia Herpes Simplex Virus Infections Market Forecast
10.3.5 India Herpes Simplex Virus Infections Market Forecast
10.3.6 Australia Herpes Simplex Virus Infections Market Forecast
10.4 Europe Herpes Simplex Virus Infections Forecast by Country (2024-2029)
10.4.1 Germany Herpes Simplex Virus Infections Market Forecast
10.4.2 France Herpes Simplex Virus Infections Market Forecast
10.4.3 UK Herpes Simplex Virus Infections Market Forecast
10.4.4 Italy Herpes Simplex Virus Infections Market Forecast
10.4.5 Russia Herpes Simplex Virus Infections Market Forecast
10.5 Middle East & Africa Herpes Simplex Virus Infections Forecast by Region (2024-2029)
10.5.1 Egypt Herpes Simplex Virus Infections Market Forecast
10.5.2 South Africa Herpes Simplex Virus Infections Market Forecast
10.5.3 Israel Herpes Simplex Virus Infections Market Forecast
10.5.4 Turkey Herpes Simplex Virus Infections Market Forecast
10.5.5 GCC Countries Herpes Simplex Virus Infections Market Forecast
10.6 Global Herpes Simplex Virus Infections Forecast by Type (2024-2029)
10.7 Global Herpes Simplex Virus Infections Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Admedus Limited
11.1.1 Admedus Limited Company Information
11.1.2 Admedus Limited Herpes Simplex Virus Infections Product Offered
11.1.3 Admedus Limited Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Admedus Limited Main Business Overview
11.1.5 Admedus Limited Latest Developments
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Information
11.2.2 Agenus Inc. Herpes Simplex Virus Infections Product Offered
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agenus Inc. Main Business Overview
11.2.5 Agenus Inc. Latest Developments
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Information
11.3.2 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Offered
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Aicuris Anti-infective Cures Gmbh Main Business Overview
11.3.5 Aicuris Anti-infective Cures Gmbh Latest Developments
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Information
11.4.2 Asahi Kasei Corporation Herpes Simplex Virus Infections Product Offered
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Asahi Kasei Corporation Main Business Overview
11.4.5 Asahi Kasei Corporation Latest Developments
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Information
11.5.2 Chimerix Inc. Herpes Simplex Virus Infections Product Offered
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Chimerix Inc. Main Business Overview
11.5.5 Chimerix Inc. Latest Developments
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Information
11.6.2 Clinigen Group Plc Herpes Simplex Virus Infections Product Offered
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Clinigen Group Plc Main Business Overview
11.6.5 Clinigen Group Plc Latest Developments
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Information
11.7.2 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Offered
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Daewoong Pharmaceutical Co., Ltd. Main Business Overview
11.7.5 Daewoong Pharmaceutical Co., Ltd. Latest Developments
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Information
11.8.2 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Offered
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 F. Hoffmann-la Roche Ltd. Main Business Overview
11.8.5 F. Hoffmann-la Roche Ltd. Latest Developments
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Information
11.9.2 Glaxosmithkline Plc Herpes Simplex Virus Infections Product Offered
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Glaxosmithkline Plc Main Business Overview
11.9.5 Glaxosmithkline Plc Latest Developments
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Information
11.10.2 Maruho Co. Ltd. Herpes Simplex Virus Infections Product Offered
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Maruho Co. Ltd. Main Business Overview
11.10.5 Maruho Co. Ltd. Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Herpes Simplex Virus Infections Product Offered
11.11.3 Merck Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Herpes Simplex Virus Infections Product Offered
11.12.3 Mylan Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Mylan Main Business Overview
11.12.5 Mylan Latest Developments
11.13 Novartis
11.13.1 Novartis Company Information
11.13.2 Novartis Herpes Simplex Virus Infections Product Offered
11.13.3 Novartis Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Novartis Main Business Overview
11.13.5 Novartis Latest Developments
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Information
11.14.2 Sanofi Pasteur Herpes Simplex Virus Infections Product Offered
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Sanofi Pasteur Main Business Overview
11.14.5 Sanofi Pasteur Latest Developments
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Information
11.15.2 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Offered
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.15.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Herpes Simplex Virus Infections Market Size 2018-2029
2.1.2 Herpes Simplex Virus Infections Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Herpes Simplex Virus Infections Segment by Type
2.2.1 General Treatment
2.2.2 Antiviral Therapy
2.3 Herpes Simplex Virus Infections Market Size by Type
2.3.1 Herpes Simplex Virus Infections Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
2.4 Herpes Simplex Virus Infections Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Herpes Simplex Virus Infections Market Size by Application
2.5.1 Herpes Simplex Virus Infections Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
3 HERPES SIMPLEX VIRUS INFECTIONS MARKET SIZE BY PLAYER
3.1 Herpes Simplex Virus Infections Market Size Market Share by Players
3.1.1 Global Herpes Simplex Virus Infections Revenue by Players (2018-2023)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2018-2023)
3.2 Global Herpes Simplex Virus Infections Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HERPES SIMPLEX VIRUS INFECTIONS BY REGIONS
4.1 Herpes Simplex Virus Infections Market Size by Regions (2018-2023)
4.2 Americas Herpes Simplex Virus Infections Market Size Growth (2018-2023)
4.3 APAC Herpes Simplex Virus Infections Market Size Growth (2018-2023)
4.4 Europe Herpes Simplex Virus Infections Market Size Growth (2018-2023)
4.5 Middle East & Africa Herpes Simplex Virus Infections Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Herpes Simplex Virus Infections Market Size by Country (2018-2023)
5.2 Americas Herpes Simplex Virus Infections Market Size by Type (2018-2023)
5.3 Americas Herpes Simplex Virus Infections Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herpes Simplex Virus Infections Market Size by Region (2018-2023)
6.2 APAC Herpes Simplex Virus Infections Market Size by Type (2018-2023)
6.3 APAC Herpes Simplex Virus Infections Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Herpes Simplex Virus Infections by Country (2018-2023)
7.2 Europe Herpes Simplex Virus Infections Market Size by Type (2018-2023)
7.3 Europe Herpes Simplex Virus Infections Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Herpes Simplex Virus Infections by Region (2018-2023)
8.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2018-2023)
8.3 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HERPES SIMPLEX VIRUS INFECTIONS MARKET FORECAST
10.1 Global Herpes Simplex Virus Infections Forecast by Regions (2024-2029)
10.1.1 Global Herpes Simplex Virus Infections Forecast by Regions (2024-2029)
10.1.2 Americas Herpes Simplex Virus Infections Forecast
10.1.3 APAC Herpes Simplex Virus Infections Forecast
10.1.4 Europe Herpes Simplex Virus Infections Forecast
10.1.5 Middle East & Africa Herpes Simplex Virus Infections Forecast
10.2 Americas Herpes Simplex Virus Infections Forecast by Country (2024-2029)
10.2.1 United States Herpes Simplex Virus Infections Market Forecast
10.2.2 Canada Herpes Simplex Virus Infections Market Forecast
10.2.3 Mexico Herpes Simplex Virus Infections Market Forecast
10.2.4 Brazil Herpes Simplex Virus Infections Market Forecast
10.3 APAC Herpes Simplex Virus Infections Forecast by Region (2024-2029)
10.3.1 China Herpes Simplex Virus Infections Market Forecast
10.3.2 Japan Herpes Simplex Virus Infections Market Forecast
10.3.3 Korea Herpes Simplex Virus Infections Market Forecast
10.3.4 Southeast Asia Herpes Simplex Virus Infections Market Forecast
10.3.5 India Herpes Simplex Virus Infections Market Forecast
10.3.6 Australia Herpes Simplex Virus Infections Market Forecast
10.4 Europe Herpes Simplex Virus Infections Forecast by Country (2024-2029)
10.4.1 Germany Herpes Simplex Virus Infections Market Forecast
10.4.2 France Herpes Simplex Virus Infections Market Forecast
10.4.3 UK Herpes Simplex Virus Infections Market Forecast
10.4.4 Italy Herpes Simplex Virus Infections Market Forecast
10.4.5 Russia Herpes Simplex Virus Infections Market Forecast
10.5 Middle East & Africa Herpes Simplex Virus Infections Forecast by Region (2024-2029)
10.5.1 Egypt Herpes Simplex Virus Infections Market Forecast
10.5.2 South Africa Herpes Simplex Virus Infections Market Forecast
10.5.3 Israel Herpes Simplex Virus Infections Market Forecast
10.5.4 Turkey Herpes Simplex Virus Infections Market Forecast
10.5.5 GCC Countries Herpes Simplex Virus Infections Market Forecast
10.6 Global Herpes Simplex Virus Infections Forecast by Type (2024-2029)
10.7 Global Herpes Simplex Virus Infections Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Admedus Limited
11.1.1 Admedus Limited Company Information
11.1.2 Admedus Limited Herpes Simplex Virus Infections Product Offered
11.1.3 Admedus Limited Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Admedus Limited Main Business Overview
11.1.5 Admedus Limited Latest Developments
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Information
11.2.2 Agenus Inc. Herpes Simplex Virus Infections Product Offered
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agenus Inc. Main Business Overview
11.2.5 Agenus Inc. Latest Developments
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Information
11.3.2 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Offered
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Aicuris Anti-infective Cures Gmbh Main Business Overview
11.3.5 Aicuris Anti-infective Cures Gmbh Latest Developments
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Information
11.4.2 Asahi Kasei Corporation Herpes Simplex Virus Infections Product Offered
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Asahi Kasei Corporation Main Business Overview
11.4.5 Asahi Kasei Corporation Latest Developments
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Information
11.5.2 Chimerix Inc. Herpes Simplex Virus Infections Product Offered
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Chimerix Inc. Main Business Overview
11.5.5 Chimerix Inc. Latest Developments
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Information
11.6.2 Clinigen Group Plc Herpes Simplex Virus Infections Product Offered
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Clinigen Group Plc Main Business Overview
11.6.5 Clinigen Group Plc Latest Developments
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Information
11.7.2 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Offered
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Daewoong Pharmaceutical Co., Ltd. Main Business Overview
11.7.5 Daewoong Pharmaceutical Co., Ltd. Latest Developments
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Information
11.8.2 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Offered
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 F. Hoffmann-la Roche Ltd. Main Business Overview
11.8.5 F. Hoffmann-la Roche Ltd. Latest Developments
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Information
11.9.2 Glaxosmithkline Plc Herpes Simplex Virus Infections Product Offered
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Glaxosmithkline Plc Main Business Overview
11.9.5 Glaxosmithkline Plc Latest Developments
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Information
11.10.2 Maruho Co. Ltd. Herpes Simplex Virus Infections Product Offered
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Maruho Co. Ltd. Main Business Overview
11.10.5 Maruho Co. Ltd. Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Herpes Simplex Virus Infections Product Offered
11.11.3 Merck Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Herpes Simplex Virus Infections Product Offered
11.12.3 Mylan Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Mylan Main Business Overview
11.12.5 Mylan Latest Developments
11.13 Novartis
11.13.1 Novartis Company Information
11.13.2 Novartis Herpes Simplex Virus Infections Product Offered
11.13.3 Novartis Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Novartis Main Business Overview
11.13.5 Novartis Latest Developments
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Information
11.14.2 Sanofi Pasteur Herpes Simplex Virus Infections Product Offered
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Sanofi Pasteur Main Business Overview
11.14.5 Sanofi Pasteur Latest Developments
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Information
11.15.2 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Offered
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.15.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Herpes Simplex Virus Infections Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of General Treatment
Table 3. Major Players of Antiviral Therapy
Table 4. Herpes Simplex Virus Infections Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 7. Herpes Simplex Virus Infections Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 10. Global Herpes Simplex Virus Infections Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Herpes Simplex Virus Infections Revenue Market Share by Player (2018-2023)
Table 12. Herpes Simplex Virus Infections Key Players Head office and Products Offered
Table 13. Herpes Simplex Virus Infections Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Herpes Simplex Virus Infections Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Herpes Simplex Virus Infections Market Size Market Share by Regions (2018-2023)
Table 18. Global Herpes Simplex Virus Infections Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Herpes Simplex Virus Infections Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Herpes Simplex Virus Infections Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Herpes Simplex Virus Infections Market Size Market Share by Country (2018-2023)
Table 22. Americas Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 24. Americas Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 26. APAC Herpes Simplex Virus Infections Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Herpes Simplex Virus Infections Market Size Market Share by Region (2018-2023)
Table 28. APAC Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 30. APAC Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 32. Europe Herpes Simplex Virus Infections Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Herpes Simplex Virus Infections Market Size Market Share by Country (2018-2023)
Table 34. Europe Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 36. Europe Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Herpes Simplex Virus Infections Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus Infections
Table 45. Key Market Challenges & Risks of Herpes Simplex Virus Infections
Table 46. Key Industry Trends of Herpes Simplex Virus Infections
Table 47. Global Herpes Simplex Virus Infections Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Herpes Simplex Virus Infections Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Herpes Simplex Virus Infections Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Herpes Simplex Virus Infections Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Admedus Limited Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 52. Admedus Limited Herpes Simplex Virus Infections Product Offered
Table 53. Admedus Limited Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Admedus Limited Main Business
Table 55. Admedus Limited Latest Developments
Table 56. Agenus Inc. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 57. Agenus Inc. Herpes Simplex Virus Infections Product Offered
Table 58. Agenus Inc. Main Business
Table 59. Agenus Inc. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Agenus Inc. Latest Developments
Table 61. Aicuris Anti-infective Cures Gmbh Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 62. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Offered
Table 63. Aicuris Anti-infective Cures Gmbh Main Business
Table 64. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Aicuris Anti-infective Cures Gmbh Latest Developments
Table 66. Asahi Kasei Corporation Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 67. Asahi Kasei Corporation Herpes Simplex Virus Infections Product Offered
Table 68. Asahi Kasei Corporation Main Business
Table 69. Asahi Kasei Corporation Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Asahi Kasei Corporation Latest Developments
Table 71. Chimerix Inc. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 72. Chimerix Inc. Herpes Simplex Virus Infections Product Offered
Table 73. Chimerix Inc. Main Business
Table 74. Chimerix Inc. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Chimerix Inc. Latest Developments
Table 76. Clinigen Group Plc Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 77. Clinigen Group Plc Herpes Simplex Virus Infections Product Offered
Table 78. Clinigen Group Plc Main Business
Table 79. Clinigen Group Plc Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Clinigen Group Plc Latest Developments
Table 81. Daewoong Pharmaceutical Co., Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 82. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Offered
Table 83. Daewoong Pharmaceutical Co., Ltd. Main Business
Table 84. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Daewoong Pharmaceutical Co., Ltd. Latest Developments
Table 86. F. Hoffmann-la Roche Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 87. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Offered
Table 88. F. Hoffmann-la Roche Ltd. Main Business
Table 89. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. F. Hoffmann-la Roche Ltd. Latest Developments
Table 91. Glaxosmithkline Plc Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 92. Glaxosmithkline Plc Herpes Simplex Virus Infections Product Offered
Table 93. Glaxosmithkline Plc Main Business
Table 94. Glaxosmithkline Plc Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Glaxosmithkline Plc Latest Developments
Table 96. Maruho Co. Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 97. Maruho Co. Ltd. Herpes Simplex Virus Infections Product Offered
Table 98. Maruho Co. Ltd. Main Business
Table 99. Maruho Co. Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Maruho Co. Ltd. Latest Developments
Table 101. Merck Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 102. Merck Herpes Simplex Virus Infections Product Offered
Table 103. Merck Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. Mylan Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 107. Mylan Herpes Simplex Virus Infections Product Offered
Table 108. Mylan Main Business
Table 109. Mylan Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Mylan Latest Developments
Table 111. Novartis Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 112. Novartis Herpes Simplex Virus Infections Product Offered
Table 113. Novartis Main Business
Table 114. Novartis Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Novartis Latest Developments
Table 116. Sanofi Pasteur Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 117. Sanofi Pasteur Herpes Simplex Virus Infections Product Offered
Table 118. Sanofi Pasteur Main Business
Table 119. Sanofi Pasteur Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Sanofi Pasteur Latest Developments
Table 121. Teva Pharmaceutical Industries Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 122. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Offered
Table 123. Teva Pharmaceutical Industries Ltd. Main Business
Table 124. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 1. Herpes Simplex Virus Infections Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of General Treatment
Table 3. Major Players of Antiviral Therapy
Table 4. Herpes Simplex Virus Infections Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 7. Herpes Simplex Virus Infections Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 10. Global Herpes Simplex Virus Infections Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Herpes Simplex Virus Infections Revenue Market Share by Player (2018-2023)
Table 12. Herpes Simplex Virus Infections Key Players Head office and Products Offered
Table 13. Herpes Simplex Virus Infections Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Herpes Simplex Virus Infections Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Herpes Simplex Virus Infections Market Size Market Share by Regions (2018-2023)
Table 18. Global Herpes Simplex Virus Infections Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Herpes Simplex Virus Infections Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Herpes Simplex Virus Infections Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Herpes Simplex Virus Infections Market Size Market Share by Country (2018-2023)
Table 22. Americas Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 24. Americas Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 26. APAC Herpes Simplex Virus Infections Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Herpes Simplex Virus Infections Market Size Market Share by Region (2018-2023)
Table 28. APAC Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 30. APAC Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 32. Europe Herpes Simplex Virus Infections Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Herpes Simplex Virus Infections Market Size Market Share by Country (2018-2023)
Table 34. Europe Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 36. Europe Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Herpes Simplex Virus Infections Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus Infections
Table 45. Key Market Challenges & Risks of Herpes Simplex Virus Infections
Table 46. Key Industry Trends of Herpes Simplex Virus Infections
Table 47. Global Herpes Simplex Virus Infections Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Herpes Simplex Virus Infections Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Herpes Simplex Virus Infections Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Herpes Simplex Virus Infections Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Admedus Limited Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 52. Admedus Limited Herpes Simplex Virus Infections Product Offered
Table 53. Admedus Limited Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Admedus Limited Main Business
Table 55. Admedus Limited Latest Developments
Table 56. Agenus Inc. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 57. Agenus Inc. Herpes Simplex Virus Infections Product Offered
Table 58. Agenus Inc. Main Business
Table 59. Agenus Inc. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Agenus Inc. Latest Developments
Table 61. Aicuris Anti-infective Cures Gmbh Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 62. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Offered
Table 63. Aicuris Anti-infective Cures Gmbh Main Business
Table 64. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Aicuris Anti-infective Cures Gmbh Latest Developments
Table 66. Asahi Kasei Corporation Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 67. Asahi Kasei Corporation Herpes Simplex Virus Infections Product Offered
Table 68. Asahi Kasei Corporation Main Business
Table 69. Asahi Kasei Corporation Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Asahi Kasei Corporation Latest Developments
Table 71. Chimerix Inc. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 72. Chimerix Inc. Herpes Simplex Virus Infections Product Offered
Table 73. Chimerix Inc. Main Business
Table 74. Chimerix Inc. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Chimerix Inc. Latest Developments
Table 76. Clinigen Group Plc Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 77. Clinigen Group Plc Herpes Simplex Virus Infections Product Offered
Table 78. Clinigen Group Plc Main Business
Table 79. Clinigen Group Plc Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Clinigen Group Plc Latest Developments
Table 81. Daewoong Pharmaceutical Co., Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 82. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Offered
Table 83. Daewoong Pharmaceutical Co., Ltd. Main Business
Table 84. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Daewoong Pharmaceutical Co., Ltd. Latest Developments
Table 86. F. Hoffmann-la Roche Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 87. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Offered
Table 88. F. Hoffmann-la Roche Ltd. Main Business
Table 89. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. F. Hoffmann-la Roche Ltd. Latest Developments
Table 91. Glaxosmithkline Plc Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 92. Glaxosmithkline Plc Herpes Simplex Virus Infections Product Offered
Table 93. Glaxosmithkline Plc Main Business
Table 94. Glaxosmithkline Plc Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Glaxosmithkline Plc Latest Developments
Table 96. Maruho Co. Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 97. Maruho Co. Ltd. Herpes Simplex Virus Infections Product Offered
Table 98. Maruho Co. Ltd. Main Business
Table 99. Maruho Co. Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Maruho Co. Ltd. Latest Developments
Table 101. Merck Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 102. Merck Herpes Simplex Virus Infections Product Offered
Table 103. Merck Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. Mylan Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 107. Mylan Herpes Simplex Virus Infections Product Offered
Table 108. Mylan Main Business
Table 109. Mylan Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Mylan Latest Developments
Table 111. Novartis Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 112. Novartis Herpes Simplex Virus Infections Product Offered
Table 113. Novartis Main Business
Table 114. Novartis Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Novartis Latest Developments
Table 116. Sanofi Pasteur Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 117. Sanofi Pasteur Herpes Simplex Virus Infections Product Offered
Table 118. Sanofi Pasteur Main Business
Table 119. Sanofi Pasteur Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Sanofi Pasteur Latest Developments
Table 121. Teva Pharmaceutical Industries Ltd. Details, Company Type, Herpes Simplex Virus Infections Area Served and Its Competitors
Table 122. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Offered
Table 123. Teva Pharmaceutical Industries Ltd. Main Business
Table 124. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Teva Pharmaceutical Industries Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Herpes Simplex Virus Infections Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Herpes Simplex Virus Infections Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Herpes Simplex Virus Infections Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Herpes Simplex Virus Infections Sales Market Share by Country/Region (2022)
Figure 8. Herpes Simplex Virus Infections Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Herpes Simplex Virus Infections Market Size Market Share by Type in 2022
Figure 10. Herpes Simplex Virus Infections in Hospital
Figure 11. Global Herpes Simplex Virus Infections Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Herpes Simplex Virus Infections in Clinic
Figure 13. Global Herpes Simplex Virus Infections Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Herpes Simplex Virus Infections in Other
Figure 15. Global Herpes Simplex Virus Infections Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Herpes Simplex Virus Infections Market Size Market Share by Application in 2022
Figure 17. Global Herpes Simplex Virus Infections Revenue Market Share by Player in 2022
Figure 18. Global Herpes Simplex Virus Infections Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 20. APAC Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 21. Europe Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 23. Americas Herpes Simplex Virus Infections Value Market Share by Country in 2022
Figure 24. United States Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Herpes Simplex Virus Infections Market Size Market Share by Region in 2022
Figure 29. APAC Herpes Simplex Virus Infections Market Size Market Share by Type in 2022
Figure 30. APAC Herpes Simplex Virus Infections Market Size Market Share by Application in 2022
Figure 31. China Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Herpes Simplex Virus Infections Market Size Market Share by Country in 2022
Figure 38. Europe Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Figure 39. Europe Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Figure 40. Germany Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 54. APAC Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 55. Europe Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 57. United States Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 58. Canada Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 61. China Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 62. Japan Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 63. Korea Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 65. India Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 66. Australia Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 67. Germany Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 68. France Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 69. UK Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 70. Italy Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 71. Russia Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 72. Spain Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 75. Israel Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 78. Global Herpes Simplex Virus Infections Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Herpes Simplex Virus Infections Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Herpes Simplex Virus Infections Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Herpes Simplex Virus Infections Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Herpes Simplex Virus Infections Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Herpes Simplex Virus Infections Sales Market Share by Country/Region (2022)
Figure 8. Herpes Simplex Virus Infections Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Herpes Simplex Virus Infections Market Size Market Share by Type in 2022
Figure 10. Herpes Simplex Virus Infections in Hospital
Figure 11. Global Herpes Simplex Virus Infections Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Herpes Simplex Virus Infections in Clinic
Figure 13. Global Herpes Simplex Virus Infections Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Herpes Simplex Virus Infections in Other
Figure 15. Global Herpes Simplex Virus Infections Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Herpes Simplex Virus Infections Market Size Market Share by Application in 2022
Figure 17. Global Herpes Simplex Virus Infections Revenue Market Share by Player in 2022
Figure 18. Global Herpes Simplex Virus Infections Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 20. APAC Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 21. Europe Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Herpes Simplex Virus Infections Market Size 2018-2023 ($ Millions)
Figure 23. Americas Herpes Simplex Virus Infections Value Market Share by Country in 2022
Figure 24. United States Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Herpes Simplex Virus Infections Market Size Market Share by Region in 2022
Figure 29. APAC Herpes Simplex Virus Infections Market Size Market Share by Type in 2022
Figure 30. APAC Herpes Simplex Virus Infections Market Size Market Share by Application in 2022
Figure 31. China Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Herpes Simplex Virus Infections Market Size Market Share by Country in 2022
Figure 38. Europe Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Figure 39. Europe Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Figure 40. Germany Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Herpes Simplex Virus Infections Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Herpes Simplex Virus Infections Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 54. APAC Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 55. Europe Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 57. United States Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 58. Canada Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 61. China Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 62. Japan Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 63. Korea Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 65. India Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 66. Australia Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 67. Germany Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 68. France Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 69. UK Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 70. Italy Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 71. Russia Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 72. Spain Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 75. Israel Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Herpes Simplex Virus Infections Market Size 2024-2029 ($ Millions)
Figure 78. Global Herpes Simplex Virus Infections Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Herpes Simplex Virus Infections Market Size Market Share Forecast by Application (2024-2029)
